Carlsmed (CARL) EBT (2024 - 2026)

Carlsmed (CARL) has reported EBT for 3 consecutive years, with -$20.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 81.02% year-over-year to -$20.5 million; the trailing twelve-month figure through Jun 2026 stood at -$76.8 million (down 67.64% YoY), and the FY2025 full-year result was -$52.2 million, down 45.47% from the prior year.
• EBT declined to -$20.5 million in Q2 2026 per CARL's latest filing, from -$16.3 million in the prior quarter.
• Across five years, EBT topped out at -$6.2 million in Q2 2024 and bottomed at -$31.5 million in Q4 2025.
• Historically, EBT has averaged -$14.3 million across 3 years, with a median of -$11.3 million in 2025.
• The widest YoY moves for EBT: up 8.68% in 2025, down 91.77% in 2025.
• Over 3 years, EBT stood at -$16.4 million in 2024, then tumbled by 91.77% to -$31.5 million in 2025, then soared by 34.89% to -$20.5 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$20.5 million, -$16.3 million, and -$31.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.